BACKGROUND Pancreatic intraductal papillary mucinous neoplasms (IPMNs) are a subset of ductal cell tumors with potential for malignancy. Because it is difficult to predict whether and when they will become malignant, management and resection are widely debated. CASE 1 A 70-year-old male with a 1-year history of epigastric pain was found to have pancreas divisum with a dominant 2.4 cm multicys...

There are still debated about surveillance interval, duration, diagnostic modality and treatment for intraductal papillary mucinous neoplasm (IPMN) of the pancreas. In recent guidelines, ‘high risk stigmata (HRS)’ ‘worrisome feature (WF)’ defined as predictive factors malignancy in IPMN. IPMNs with HRS main duct- IPMN more likely to accompany malignancies, thus require surgery. However, case on...